88 related articles for article (PubMed ID: 17690559)
1. Twist expression predicts poor clinical outcome of patients with clear cell carcinoma of the ovary.
Kajiyama H; Hosono S; Terauchi M; Shibata K; Ino K; Yamamoto E; Nomura S; Nawa A; Kikkawa F
Oncology; 2006; 71(5-6):394-401. PubMed ID: 17690559
[TBL] [Abstract][Full Text] [Related]
2. Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary.
Sekiya R; Kajiyama H; Sakai K; Umezu T; Mizuno M; Shibata K; Yamamoto E; Fujiwara S; Nagasaka T; Kikkawa F
Hum Pathol; 2012 Jun; 43(6):904-10. PubMed ID: 22169254
[TBL] [Abstract][Full Text] [Related]
3. Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients.
Hosono S; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
Br J Cancer; 2007 Jan; 96(2):314-20. PubMed ID: 17211477
[TBL] [Abstract][Full Text] [Related]
4. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
[TBL] [Abstract][Full Text] [Related]
5. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status.
Fondrevelle ME; Kantelip B; Reiter RE; Chopin DK; Thiery JP; Monnien F; Bittard H; Wallerand H
Urol Oncol; 2009; 27(3):268-76. PubMed ID: 18440840
[TBL] [Abstract][Full Text] [Related]
6. Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary.
Umezu T; Shibata K; Kajiyama H; Yamamoto E; Nawa A; Kikkawa F
J Clin Pathol; 2010 Nov; 63(11):962-6. PubMed ID: 20972242
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive values of E-cadherin for patients of ovarian clear cell adenocarcinoma.
Ho CM; Cheng WF; Lin MC; Chen TC; Huang SH; Liu FS; Chien CC; Yu MH; Wang TY; Hsieh CY
Int J Gynecol Cancer; 2010 Dec; 20(9):1490-7. PubMed ID: 21119364
[TBL] [Abstract][Full Text] [Related]
8. KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear‑cell carcinoma cells.
Kawai Y; Shibata K; Sakata J; Suzuki S; Utsumi F; Niimi K; Sekiya R; Senga T; Kikkawa F; Kajiyama H
Oncol Rep; 2018 Jul; 40(1):195-205. PubMed ID: 29749467
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases.
Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K
Medicine (Baltimore); 2016 Mar; 95(9):e3003. PubMed ID: 26945423
[TBL] [Abstract][Full Text] [Related]
10. Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.
Itamochi H; Oumi N; Oishi T; Shoji T; Fujiwara H; Sugiyama T; Suzuki M; Kigawa J; Harada T
Int J Clin Oncol; 2015 Oct; 20(5):967-73. PubMed ID: 25744580
[TBL] [Abstract][Full Text] [Related]
11. Significance of TWIST expression and its association with E-cadherin in bladder cancer.
Zhang Z; Xie D; Li X; Wong YC; Xin D; Guan XY; Chua CW; Leung SC; Na Y; Wang X
Hum Pathol; 2007 Apr; 38(4):598-606. PubMed ID: 17258791
[TBL] [Abstract][Full Text] [Related]
12. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.
Higashi M; Kajiyama H; Shibata K; Mizuno M; Mizuno K; Hosono S; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
Gynecol Oncol; 2011 Dec; 123(3):474-8. PubMed ID: 21955484
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Lopes CS
Ann Oncol; 2004 Oct; 15(10):1535-42. PubMed ID: 15367415
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Twist and E-cadherin in patients with osteosarcoma.
Yin K; Liao Q; He H; Zhong D
Med Oncol; 2012 Dec; 29(5):3449-55. PubMed ID: 22847601
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.
Itamochi H; Oumi N; Oishi T; Taniguchi F; Shoji T; Fujiwara H; Sugiyama T; Suzuki M; Kigawa J; Harada T
Int J Gynecol Cancer; 2015 May; 25(4):570-6. PubMed ID: 25756405
[TBL] [Abstract][Full Text] [Related]
16. Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3.
Min KW; Park MH; Hong SR; Lee H; Kwon SY; Hong SH; Joo HJ; Park IA; An HJ; Suh KS; Oh HK; Yoo CW; Kim MJ; Chang HK; Jun SY; Yoon HK; Chang ED; Kim DW; Kim I;
Int J Gynecol Pathol; 2013 Jan; 32(1):3-14. PubMed ID: 23202783
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma.
Terauchi M; Kajiyama H; Yamashita M; Kato M; Tsukamoto H; Umezu T; Hosono S; Yamamoto E; Shibata K; Ino K; Nawa A; Nagasaka T; Kikkawa F
Clin Exp Metastasis; 2007; 24(5):329-39. PubMed ID: 17487558
[TBL] [Abstract][Full Text] [Related]
18. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.
Takaya A; Peng WX; Ishino K; Kudo M; Yamamoto T; Wada R; Takeshita T; Naito Z
Int J Oncol; 2015 Apr; 46(4):1573-81. PubMed ID: 25633807
[TBL] [Abstract][Full Text] [Related]
19. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis.
Yuen HF; Chan YP; Wong ML; Kwok WK; Chan KK; Lee PY; Srivastava G; Law SY; Wong YC; Wang X; Chan KW
J Clin Pathol; 2007 May; 60(5):510-4. PubMed ID: 16822877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
